Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CVRx Inc CVRX

Healthcare Medical Devices
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS... see more

Recent & Breaking News (NDAQ:CVRX)

CVRx to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call

GlobeNewswire July 14, 2022

CVRx Launches a new Barostim(TM) Programmer

GlobeNewswire July 12, 2022

CVRx to Present at the William Blair 42nd Annual Growth Stock Conference

GlobeNewswire May 23, 2022

CVRx® Receives MR-Conditional Labeling Approval for its Barostim(TM) Heart Failure System

GlobeNewswire May 9, 2022

CVRx Reports First Quarter 2022 Financial and Operating Results

GlobeNewswire April 25, 2022

CVRx to Report First Quarter 2022 Financial and Operating Results and Host Conference Call

GlobeNewswire April 12, 2022

CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

GlobeNewswire February 15, 2022

CVRx to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 15, 2022

GlobeNewswire February 1, 2022

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

GlobeNewswire January 10, 2022

CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 21, 2021

CVRx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire November 16, 2021

CVRx Reports Third Quarter 2021 Financial and Operating Results

GlobeNewswire November 4, 2021

CVRx to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call

GlobeNewswire October 21, 2021

CVRx Added to Russell 2000® and 3000® Indexes

GlobeNewswire September 17, 2021

CVRx Reports Second Quarter 2021 Financial and Operating Results

GlobeNewswire August 4, 2021

CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference

GlobeNewswire July 29, 2021

CVRx to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call

GlobeNewswire July 21, 2021

CVRx Welcomes Veteran Life Science Industry Leader Martha Shadan to its Board of Directors

GlobeNewswire July 12, 2021

Treo Ventures Announces the Successful IPO of its Portfolio Company CVRx® (NSDQ: CVRX)

PR Newswire July 6, 2021

CVRx, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire July 2, 2021